In 2015, Lawrence was appointed the director of the University of Michigan Rogel Cancer Center.
With his medical degree, Lawrence then completed his residency in internal medicine at Stanford University and National Cancer Institute.
[3] During his early tenure at the institution, he developed combined treatments of intensified chemotherapy and radiation for patients with pancreatic cancer.
[5] In 2007, Larence was recognized for his scientific achievements with an election to the National Academy of Medicine.
[4] A few years later, he was the recipient of the 2009 Gold Medal from the American Society for Radiation Oncology.